The role of adiponectin, a marker of the metabolic syndrome, on the pathogenesis of hypertension in comparison with markers of adipose tissue mass (leptin) and inflammation (high-sensitivity C-reactive protein [hs-CRP]) remains to be clarified. The eligible study population consisted of 2,045 residents aged≥40 years who had participated in a community-based survey and had complete data for serum adiponectin, leptin, and hs-CRP, and for whom homeostasis model assessment of insulin resistance (HOMA-IR) had been calculated from insulin and plasma glucose. Among all eligible participants, as well as in the subgroup of nondiabetic normotensives (blood pressure <140/90 mmHg and without antihypertensive medication), all three markers were significantly correlated with systolic blood pressure (negative correlation for adiponectin and positive correlations for leptin and hs-CRP). Among all participants, systolic blood pressure and the presence of hypertension were determined mainly by age, sex, body mass index, and waist circumference. None of the markers further contributed to the multivariate linear regression or logistic regression models. In contrast, adiponectin, but not leptin, hs-CRP, or HOMA-IR, was significantly associated with systolic blood pressure and the presence of pre-hypertension (blood pressure within 120–139/80–89 mmHg) after adjustment for age, sex, body mass index, and waist circumference in the nondiabetic normotensive subgroup. Similarly, adiponectin was independently associated with diastolic blood pressure in the nondiabetic normotensive subgroup but not in the whole population. In conclusion, adiponectin, but not leptin or hs-CRP, was independently associated with blood pressure in a nondiabetic normotensive subgroup.
Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Alberti KG, Zimmet P, Shaw J : The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 1059–1062.
Chuang SY, Chou P, Hsu PF, et al: Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens 2006; 19: 788–795.
Jazet IM, Pijl H, Meinders AE : Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 2003; 61: 194–212.
Brooks NL, Moore KS, Clark RD, et al: Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab 2007; 9: 246–258.
Beltowski J : Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24: 789–801.
Hak AE, Stehouwer CD, Bots ML, et al: Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19: 1986–1991.
Barba G, Russo O, Siani A, et al: Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160–166.
Chow WS, Cheung BM, Tso AW, et al: Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007; 49: 1455–1461.
Engstrom G, Janzon L, Berglund G, et al: Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002; 22: 2054–2058.
Sesso HD, Buring JE, Rifai N, et al: C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945–2951.
Wasim H, Al Daghri NM, Chetty R, et al: Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006; 5: 10.
Hopkins TA, Ouchi N, Shibata R, et al: Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11–18.
Duncan BB, Schmidt MI, Pankow JS, et al: Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004; 53: 2473–2478.
Pischon T, Girman CJ, Hotamisligil GS, et al: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737.
Schillaci G, Pirro M : Hypoadiponectinemia: a novel link between obesity and hypertension? Hypertension 2007; 49: 1217–1219.
Han SH, Quon MJ, Kim JA, et al: Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007; 49: 531–538.
Ohashi K, Kihara S, Ouchi N, et al: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47: 1108–1116.
Yamamoto Y, Hirose H, Saito I, et al: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002; 103: 137–142.
Huang KC, Chen CL, Chuang LM, et al: Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003; 88: 4130–4134.
Dogru T, Sonmez A, Tasci I, et al: Plasma adiponectin and insulin resistance in new onset hypertension. Endocrine 2006; 29: 405–408.
Cesari M, Pessina AC, Zanchetta M, et al: Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients. J Intern Med 2006; 260: 474–483.
Imai J, Katagiri H, Yamada T, et al: Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring) 2006; 14: 1132–1141.
Furuhashi M, Ura N, Higashiura K, et al: Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42: 76–81.
Iwashima Y, Katsuya T, Ishikawa K, et al: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318–1323.
Kazumi T, Kawaguchi A, Sakai K, et al: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25: 971–976.
Furuhashi M, Ura N, Higashiura K, et al: Low adiponectin level in young normotensive men with a family history of essential hypertension. Hypertens Res 2005; 28: 141–146.
Patel DA, Srinivasan SR, Xu JH, et al: Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006; 55: 1551–1557.
Sharma AM, Chetty VT : Obesity, hypertension and insulin resistance. Acta Diabetol 2005; 42 ( Suppl 1): S3–S8.
Bautista LE, Lopez-Jaramillo P, Vera LM, et al: Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857–861.
Lakoski SG, Cushman M, Palmas W, et al: The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005; 46: 1869–1874.
Warnberg J, Nova E, Moreno LA, et al: Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 2006; 84: 505–512.
Carr DB, Utzschneider KM, Hull RL, et al: Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087–2094.
Saad MF, Rewers M, Selby J, et al: Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension 2004; 43: 1324–1331.
Bonora E, Kiechl S, Willeit J, et al: Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007; 30: 318–324.
About this article
Cite this article
Sung, SH., Chuang, SY., Sheu, WH. et al. Adiponectin, but Not Leptin or High-Sensitivity C-Reactive Protein, Is Associated with Blood Pressure Independently of General and Abdominal Adiposity. Hypertens Res 31, 633–640 (2008). https://doi.org/10.1291/hypres.31.633
- metabolic syndrome
Plasma Leptin Concentration and Sympathetic Nervous Activity in Older Adults With Physical Dysfunction
Journal of the Endocrine Society (2018)
Journal of Human Hypertension (2012)
Journal of Human Hypertension (2011)
Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status
Journal of Human Hypertension (2010)